27 results
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Osteoporosis Treatment ... for causes of secondary ... • Recommend pharmacologic ... benefits and risks of medications
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
of Weight-Loss Medications ... the long-term treatment ... mg #Obesity #Medications ... WeightLoss #AACE #2016 ... #Pharmacology #
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
anesthesiology #treatment ... #medications ... amp; Mishra, R. (2015 ... Pharmacology of ... neuromuscular pharmacology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... After non-pharmacologic ... options, first-line treatment ... is the newest medication ... #Medications #Pharmacology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... has its own benefits ... #pharmacology #pharmacotherapy ... comparison #management #medications ... endocrinology #treatment
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Bethanechol • Used in treatment ... during ocular surgery ... as first-line treatments ... in ophthalmic surgery ... Cholinergic #Agonists #Pharmacology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... therapy is non-pharmacologic ... patients using TCS ... Dermatitis #Topical #Treatment ... #Medications #Pharmacology
Rhinitis medication treatments comparison

Source: Scholes, Melissa A., and Vijay R. Ramakrishnan. 2016. ENT secrets.  

#otolaryngology
Rhinitis medication ... treatments comparison ... Ramakrishnan. 2016 ... #embryology ; #surgery
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 ... daily The 2019 ... recommendations for the treatment ... the use of this medication ... #Pharmacology #
A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD
summary of the pharmacologic ... acute bleeding and secondary ... LVAD #Bleeding #Pharmacology ... #Management #Treatment ... #Medications #Secondary